SINTX Technologies

NASDAQ: SINT

A silicon nitride ceramics company for spinal and orthopaedic implants. Its 3D printing work is a silicon nitride and PEEK composite for patient-specific spinal implants, funded in part by NIH grants.

Status
Listed
Listing
NASDAQ: SINT
Headquarters
Salt Lake City, Utah, United States
Ownership
Listed on Nasdaq (SINT)
Technologies
silicon nitride, silicon nitride-PEEK, patient-specific implants

Live chart and quote by TradingView. Data may be delayed.

Timeline

4 entries, oldest first
  1. 2021
    Sep 2021

    Receives a first NIH grant of 308,301 dollars for a 3D printed silicon nitride-PEEK spinal implant

    Source

  2. 2023
    Oct 2023

    Awarded a 1,972,826 dollar Phase II NIH grant for 3D printed silicon nitride-PEEK composite spinal implants

    Source

  3. 2025
    Dec 2025

    Signs a supply agreement with Evonik to make the silicon nitride-PEEK compound at commercial scale for AI-assisted printing of patient-specific implants

    Source

  4. 2026
    Aug 2026

    Finishes building a 3D printing facility for its SiNERGY patient-specific silicon nitride-PEEK implants and gets a 12-month NIH extension

    About 745,000 dollars remained on the 1.97 million dollar grant.

    Source

Last checked . Informational only, not investment advice. Timeline entries are compiled by hand from public sources and can lag real events. Figures come from company reports and news, not from us. Private companies rarely publish financials; where a figure is not disclosed we say so instead of estimating it. This page as JSON, free to use with a credit: open data.